Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Nuclear Medicine Program progress report for quarter ending June 30, 1990

Technical Report ·
OSTI ID:6939010
In this a report novel electrochemical method is described for the separation of copper-64 and copper-67 following the irradiation of zinc targets. This method is based on the spontaneous electrodeposition of copper on a platinum electrode immersed in the zinc target solution without requiring an external electromotive force (EMF). No-carrier-added N-(2-(3-({sup 125}I)iodo-4-hydroxyphenyl)ethyl)-maleimide has been prepared by direct iodination of N-(2-(4-hydroxyphenyl)ethyl)-maleimide with (Na({sup 125}I)-chloramine-T). The precursor was prepared by condensation of tyramine with maleic anhydride followed by ring annulation. Studies in rats showed low thyroid uptake of radioactivity which reached a plateau after 4 h, indicating in vivo stability. This new radioiodinated maleimide analogue reacts with bovine serum albumin (BSA) under mild conditions and has been used for labeling a lung-endothelial-cell-specific antibody (411-201B). The ({sup 125}I)-labeled antibodies are currently being evaluated for immunoreactivity and tumor specificity. During this period several agents were also supplied to Medical Cooperative investigators, including iodine-123-labeled and iodine-131-labeled fatty acid analogues for studies at the Brookhaven National Laboratory, the Cardiology Department at the Free University of Amsterdam, and the University of Bonn, West Germany. A tungsten-188/rhenium-188 generator was supplied to the University of Massachusetts, and osmium-191 was supplied for fabrication of generators for patient studies in Finland. 4 refs., 5 figs., 5 tabs.
Research Organization:
Oak Ridge National Lab., TN (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
AC05-84OR21400
OSTI ID:
6939010
Report Number(s):
ORNL/TM-11570; ON: DE90016681
Country of Publication:
United States
Language:
English

Similar Records

Nuclear Medicine Program progress report for quarter ending March 31, 1990
Technical Report · Sun Jul 01 00:00:00 EDT 1990 · OSTI ID:7015943

Nuclear Medicine Program progress report for quarter ending September 30, 1990
Technical Report · Thu Jan 31 23:00:00 EST 1991 · OSTI ID:6228890

The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: A comparison of nine radiolabels
Journal Article · Sun May 01 00:00:00 EDT 1994 · Journal of Nuclear Medicine · OSTI ID:95914